4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001193125-25-309666
CEO & President sold 2,662 shares at $20.72 ($55,157)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cox John CEO & President | 2025-12-05 | Sale 10b5-1 | −2,662 | $20.72 | $55,157 | 196,877 | D: show line 1 in the form |
| Open-market sales · 2,662 sh · avg $20.72 · $55,157 | |||||||
Loading xslF345X05/ownership.xml…